| Schedule of revenue from contract with customer and other income by nature |
| | | | | | | | | 2025 | | 2024 | | 2023* | Collaborative research funding | | 29,972 | | 404,102 | | 1,612,953 | Fair value of services received at zero cost from Neurosterix Group | | 141,018 | | — | | — | Other service income | | 1,870 | | 5,940 | | 4,235 | Total | | 172,860 | | 410,042 | | 1,617,188 |
|
| Schedule of revenue from contract with customer and other income by major counterparties |
| | | | | | | | | 2025 | | 2024 | | 2023* | Indivior PLC | | 29,972 | | 404,102 | | 1,612,953 | Neurosterix Group | | 141,018 | | — | | — | Other counterparties | | 1,870 | | 5,940 | | 4,235 | Total | | 172,860 | | 410,042 | | 1,617,188 |
|
| Schedule of geographical areas |
The geographical allocation of long-lived assets is detailed as follows: | | | | | | | December 31, | | December 31, | | | 2025 | | 2024 | Switzerland | | 4,683,813 | | 7,136,602 | France | | 335 | | 338 | Total | | 4,684,148 | | 7,136,940 |
The geographical analysis of operating costs is as follows: | | | | | | | | | 2025 | | 2024 | | 2023* | Switzerland | | 2,974,125 | | 3,129,444 | | 3,844,670 | United States of America | | 8,942 | | 31,276 | | 11,117 | France | | 4,391 | | 4,555 | | 4,368 | Total operating costs (note 17) | | 2,987,458 | | 3,165,275 | | 3,860,155 |
|